Strong Balance Sheet Stocks

Results

94

6 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

94 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
	SCGLR New	€19.80	0%	n/a	€97.0m	n/a	1.0	n/a	0.9%	Real Estate
	DOMO	€1.39	0%	12.1%	€15.7m	n/a	0.8	n/a	0%	Real Estate Management and Development
	YINB2	€0.99	0%	1.0%	€24.6m	n/a	1.1	n/a	0.3%	Real Estate
	DESA	€24.20	0%	46.7%	€43.1m	€26.80	10.4	-2.9%	4.6%	Capital Goods
	PHM	€77.70	-3.1%	-1.5%	€1.3b	€104.39	24.0	37.2%	1.3%	Pharmaceuticals & Biotech
	ART	€28.60	-3.1%	138.3%	€1.6b	€34.25	29.4	21.0%	0.6%	Capital Goods
	PRM	€13.35	0%	11.7%	€227.1m	€16.75	17.4	9.0%	4.0%	Healthcare
	UBS	€0.0021	0%	-38.2%	€98.1m	n/a	0.6	n/a	n/a	Real Estate Management and Development
	EBRO	€18.28	0.1%	6.7%	€2.8b	€20.40	12.7	2.0%	3.8%	Food, Beverage & Tobacco
	NTH	€2.55	-0.4%	37.1%	€154.1m	n/a	15.1	n/a	7.8%	Retail
	SNG	€2.08	0%	-28.8%	€107.2m	n/a	18.0	n/a	1.9%	Software
	ACS New	€109.30	-0.3%	78.2%	€30.5b	€127.48	30.0	14.3%	2.1%	Capital Goods
	VYT	€17.60	3.5%	220.0%	€129.3m	n/a	45.7	n/a	n/a	Household
	ITX	€58.80	2.3%	38.9%	€182.2b	€59.54	29.1	8.5%	3.0%	Retail
	APG	€17.00	0%	6.9%	€88.5m	n/a	13.9	12.3%	5.2%	Diversified Financials
	ENO	€33.50	-4.7%	43.8%	€2.8b	€41.88	22.1	11.8%	1.6%	Capital Goods
	BST	€0.23	12.8%	-36.9%	€17.0m	n/a	5.0	n/a	n/a	Pharmaceuticals & Biotech
	AYC	€0.55	0%	-4.4%	€18.1m	n/a	4.9	n/a	n/a	Real Estate Management and Development
	TRH	€1.00	0%	0%	€300.0k	n/a	0.3	n/a	n/a	Consumer Services
	A3M	€5.12	-2.5%	4.0%	€1.1b	€5.47	21.1	15.9%	7.6%	Media
	GRI	€1.66	5.1%	56.6%	€50.4m	n/a	20.8	n/a	n/a	Commercial Services
	REP	€25.46	-3.9%	91.7%	€27.7b	€27.08	8.1	-6.3%	4.2%	Energy
	GSJ	€8.10	1.0%	29.4%	€528.0m	€10.08	11.5	-3.1%	2.2%	Capital Goods
	FACE	€1.75	-1.1%	-33.4%	€47.1m	€3.70	145.0	54.2%	n/a	Software

Page 1 of 3